ACETO Completes the Sale of Rising Pharmaceuticals
April 22 2019 - 8:00AM
ACETO Corporation (Nasdaq: ACETQ), an international company engaged
in the development, marketing, sale and distribution of Human
Health products, Pharmaceutical Ingredients and Performance
Chemicals, announced today that it has completed the previously
disclosed sale of the assets of Rising Pharmaceuticals and Rising’s
subsidiaries to Shore Suven Pharma, Inc.
Additional information about Aceto’s Chapter 11 cases can be
found at http://cases.primeclerk.com/Aceto and by calling
844-216-7718, a toll-free number for callers in the U.S. and
Canada, or 347-761-3238, for international callers.
About
ACETO
ACETO Corporation, incorporated in 1947, is focused
on the global marketing, sale and distribution of Human Health
products (finished dosage form generics and nutraceutical
products), Pharmaceutical Ingredients (pharmaceutical intermediates
and active pharmaceutical ingredients) and Performance Chemicals
(specialty chemicals and agricultural protection products). With
business operations in nine countries, ACETO distributes over 1,100
chemical compounds used principally as finished products or raw
materials in the pharmaceutical, nutraceutical, agricultural,
coatings and industrial chemical industries. ACETO's global
operations, including a staff of 25 in China and 12 in India, are
distinctive in the industry and enable its worldwide sourcing and
regulatory capabilities.
Company Contact: Jody BurfeningCommunications
Consultant jburfening@lhai.com(212) 838-3777
Adicet Bio (NASDAQ:ACET)
Historical Stock Chart
From Mar 2024 to Apr 2024
Adicet Bio (NASDAQ:ACET)
Historical Stock Chart
From Apr 2023 to Apr 2024